v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Dec. 31, 2024   42,348,643      
Beginning balance at Dec. 31, 2024 $ (66,064) $ 423 $ 806,231 $ (5,406) $ (867,312)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 750   750    
Other comprehensive income 262     262  
Net income (loss) (7,061)       (7,061)
Ending balance (in shares) at Mar. 31, 2025   42,348,643      
Ending balance at Mar. 31, 2025 $ (72,113) $ 423 806,981 (5,144) (874,373)
Beginning balance (in shares) at Dec. 31, 2025 43,326,339 43,326,339      
Beginning balance at Dec. 31, 2025 $ (114,956) $ 433 808,432 (5,187) (918,634)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 1,890   1,890    
Issuance of common stock under stock compensation plan, net of forfeitures (in shares)   (15,562)      
Other comprehensive income 158     158  
Net income (loss) 107,879       107,879
Cancellation of Predecessor equity (in shares)   (43,310,777)      
Cancellation of Predecessor equity 5,029 $ (433) (810,322) 5,029 810,755
Issuance of Successor common stock (in shares)   13,949,990      
Issuance of Successor common stock 135,204 $ 139 135,065    
Ending balance (in shares) at Mar. 05, 2026   13,949,990      
Ending balance at Mar. 05, 2026 135,204 $ 139 135,065 0 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive income 32     32  
Net income (loss) $ (1,253)       (1,253)
Ending balance (in shares) at Mar. 31, 2026 13,949,990 13,949,990      
Ending balance at Mar. 31, 2026 $ 133,983 $ 139 $ 135,065 $ 32 $ (1,253)